Chronic pain affects an estimated 50 million adults in the United States and is one of the leading causes of disability worldwide. Many patients with chronic pain do not find adequate relief from conventional treatments, and long-term opioid use carries significant risks. Ketamine, originally developed as an anesthetic, has well-established analgesic properties and is increasingly being investigated as a treatment for chronic pain conditions, particularly those involving neuropathic mechanisms or central sensitization.
A systematic review by Orhurhu et al. (2019), published in Pain Physician, analyzed multiple studies on ketamine for chronic pain and concluded that ketamine demonstrated analgesic benefit across several chronic pain conditions, including neuropathic pain and complex regional pain syndrome (CRPS). A Cochrane review (Connolly et al., 2015) found that ketamine may provide short-term pain relief for certain refractory chronic pain conditions, though evidence for long-term benefit was limited.
For neuropathic pain specifically, a consensus statement from the American Society of Regional Anesthesia and Pain Medicine (Cohen et al., 2018) acknowledged ketamine as a reasonable option for patients who have not responded to more conventional therapies. It is important to note that ketamine is not FDA-approved specifically for chronic pain management, and outcomes depend on the type and severity of the pain condition. Treatment should be pursued under physician supervision with realistic expectations about potential benefits.
1. Consultation
A 60-minute telehealth evaluation with a physician. We assess your pain condition, current treatments, medication history, and whether ketamine therapy may be suitable for your situation.
2. Personalized protocol
If ketamine is appropriate, your physician designs a tailored treatment plan considering your specific pain type and severity. Medication is prescribed and delivered to your home.
3. Ongoing monitoring
Your physician tracks your pain levels, functional improvement, and any side effects through regular follow-up appointments, adjusting your protocol as needed.
Ketamine has well-established analgesic properties and has been used in pain medicine for decades. Research suggests that low-dose ketamine may help reduce chronic pain, particularly neuropathic pain and conditions involving central sensitization. However, its use for chronic pain is off-label, and outcomes vary by individual and pain type.
Studies have investigated ketamine for neuropathic pain, complex regional pain syndrome (CRPS), fibromyalgia, and chronic headache or migraine conditions. Evidence is strongest for neuropathic pain and CRPS, though results vary. Your physician will assess whether your specific pain condition may be appropriate for ketamine therapy.
Ketamine is FDA-approved as an anesthetic and has well-recognized analgesic properties. However, its specific use for chronic pain management is considered off-label. It is prescribed by licensed physicians based on clinical judgment and the available evidence.
Some research suggests that ketamine may have opioid-sparing effects, meaning it could potentially help reduce reliance on opioid medications for pain management. However, this should only be explored under close physician supervision, and any changes to opioid medications must be managed carefully.
Ready to explore ketamine therapy for chronic pain?
Appointments often available within 24 hours.
Check Appointment Availability